axagliptin intermediate

Orforglipron (2212020-52-3) is an oral GLP-1 receptor agonist for type 2 diabetes and obesity research. Available for R&D use under patent.

Survodutide is a dual GCGR/GLP-1R agonist for R&D. It increases energy expenditure, improves liver fibrosis, reduces appetite, and enhances satiety. White powder, CAS 2805997-46-8.

Cetrorelix acetate (130143-01-0) is a synthetic GnRH antagonist for IVF, preventing premature ovulation. White powder, -20°C storage. For R&D use.

Atosiban acetate (914453-95-5) is a synthetic oxytocin antagonist for inhibiting premature uterine contractions. Available as white powder with high purity for R&D use.

Teriparatide Acetate (52232-67-4) is a synthetic peptide for osteoporosis treatment. White powder form, high purity, for R&D use under patent.

Octreotide Acetate (83150-76-9) is a potent synthetic octapeptide with long-lasting effects for endocrine and digestive disorders. White powder, high purity for R&D use.

Eptifibatide (188627-80-7) is a potent GP IIb/IIIa inhibitor antiplatelet drug for acute coronary syndrome and PCI. Supplied as white powder with 831.96 molecular weight. For R&D use only.

High-purity 98% citric acid (CAS 77-92-9) with 2-year shelf life. Ideal as pH adjuster, preservative & antioxidant. Industrial-grade in 25kg drums for B2B applications.